FDG-PET is Superior to Gallium Scintigraphy in Staging and More Sensitive in the Follow-up of Patients with<i>de novo</i>Hodgkin Lymphoma: A Blinded Comparison

Wylie B.R., 1989, "Gallium scanning in the management of mediastinal Hodgkin's disease", European Journal of Haematology, 42, 344

Salloum E., 1997, Journal of Clinical Oncology, 15, 518— 527

King S.C., 1994, "Prognostic importance of restaging gallium scans following induction che-motherapy for advanced Hodgkin's disease", Journal of Clinical Oncology, 12, 306

Coiffier B, 1999, "How to interpret the radiological abnormalities that persist after treatment in non-Hodgkin's lymphoma patients?", Annals of Oncology, 10, 1141

Weihrauch M.R., 2001, Blood, 98, 2930 — 2934

Moog F., 1998, detection with FDG PET versus CT", Radiology, 206, 475

Carr R., 1998, Blood, 91, 3340— 3346

Moog F., 1998, Journal of Clinical Oncology, 603, 10.1200/JCO.1998.16.2.603

Harris N.L., 1999, Journal of Clinical Oncology, 17, 3835 — 3849

Cutler P.D., 1996, Physics Medicine Biology, 41, 1453 — 1467

Hudson H.M., 1996, "Accelerated image reconstruction using ordered subsets of projection data", IEEE Translational Medical Imaging, 13, 601 — 609

10.1080/01621459.1958.10501452

Hagemeister F.B., 1990, "Role of the gallium scan in Hodgkin's disease", Cancer, 65, 1090— 1096

Blackwell E.A., 1986, High-dose gallium scanning obviates the need for staging laparotomy", Cancer, 58, 883

Delcambre C., 2000, European Journal of Nuclear Medicine, 27, 176 — 184

Stomper P.C., 1993, CT-lymphangiography-Ga- 67 scanning correlation", Radiology, 187, 381— 386

Hagemeister F.B., 1994, "The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy", Annals of Oncology, 5, 59

10.1148/radiology.210.2.r99fe07487

Gasparini M.D., 1993, "Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin lymphoma", Cancer, 72, 577

Tucker R., 2001, first year's experi-ence in a clinical center", Journal of Clinical Oncology, 19, 2504 — 2508

Hueltenschmidt B, 2001, Cancer, 91, 302 — 310

10.1016/S1040-8428(01)00127-5

10.1023/A:1008486928190

Shah N., 2000, "The impact of FDG positron emission tomography imaging on the management of lymphomas", British Journal of Radiology, 73, 482

Partridge S., 2000, Annals of Oncology, 11, 1273 — 1279

Buchmann I., 2001, A bicenter trial", Cancer, 91, 889

Jerusalem G., 1999, Blood, 429, 10.1182/blood.V94.2.429

10.1046/j.1365-2141.2001.03147.x

10.1016/S0959-8049(99)00249-X

Zinzani P.L., 1999, "The role of positron emission tomography (PET) in the management of lymphoma patients", Annals of Oncology, 10, 1181

Kostakoglu L., 2002, Cancer, 94, 879 — 888

10.1016/S0002-9343(01)01117-2

Shen Y.Y., 2002, Oncology Reports, 9, 321 —325

Romer W., 1998, assessment of chemotherapy with fluoro-deoxyglucose", Blood, 91, 4464

10.1200/JCO.20.5.1398

10.1007/s002590050356

Wiedmann E., 1999, "Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease", Leukemia and Lymphoma, 34, 545 — 551